Odenwald

Heidelberg starts new financial year with high order volume and improved operating profitability

Retrieved on: 
Wednesday, August 4, 2021

HEIDELBERG, Germany, Aug. 4, 2021 /PRNewswire/ -- Heidelberger Druckmaschinen AG (Heidelberg) has made a positive start to financial year 2021/22 (April1, 2021 to March31, 2022).

Key Points: 
  • HEIDELBERG, Germany, Aug. 4, 2021 /PRNewswire/ -- Heidelberger Druckmaschinen AG (Heidelberg) has made a positive start to financial year 2021/22 (April1, 2021 to March31, 2022).
  • "As demonstrated by our encouraging initial quarter of financial year 2021/22, Heidelberg is really delivering!
  • Based on solid economic development, Heidelberg is expecting the profitable upward trend to continue in subsequent years, too.
  • For example, the company even improved on EBITDA as recorded in the corresponding quarter of financial year 2019/20, i.e.

Heidelberg expecting profitable growth in FY 2021/2022 and subsequent years

Retrieved on: 
Wednesday, June 9, 2021

"The comprehensive transformation Heidelberg initiated before the coronavirus pandemic hit has made the company leaner and more efficient.

Key Points: 
  • "The comprehensive transformation Heidelberg initiated before the coronavirus pandemic hit has made the company leaner and more efficient.
  • With solid economic development, this profitable upward trend looks set to continue in subsequent years, too.
  • This is down to the company's successful implementation of realignment measures, the focus on its profitable core business, and the expansion of growth areas.
  • Heidelberg sees considerable potential for sustained growth and increases in value in the futureabove all for packaging printing, digital business models, business in China, and new technology applications.

Heidelberg expecting profitable growth in FY 2021/2022 and subsequent years

Retrieved on: 
Wednesday, June 9, 2021

"The comprehensive transformation Heidelberg initiated before the coronavirus pandemic hit has made the company leaner and more efficient.

Key Points: 
  • "The comprehensive transformation Heidelberg initiated before the coronavirus pandemic hit has made the company leaner and more efficient.
  • With solid economic development, this profitable upward trend looks set to continue in subsequent years, too.
  • This is down to the company's successful implementation of realignment measures, the focus on its profitable core business, and the expansion of growth areas.
  • Heidelberg sees considerable potential for sustained growth and increases in value in the futureabove all for packaging printing, digital business models, business in China, and new technology applications.

DGAP-News: Heidelberger Druckmaschinen AG: Heidelberg wallboxes far exceed sales expectations - e-mobility business already profitable

Retrieved on: 
Tuesday, May 11, 2021

Furthermore, despite increased growth investments, Heidelberg has already achieved a positive margin for its electric vehicle charging stations (wallboxes).

Key Points: 
  • Furthermore, despite increased growth investments, Heidelberg has already achieved a positive margin for its electric vehicle charging stations (wallboxes).
  • The company has sold some 45,000 wallboxes to end customers since 2018.\n"With its wallboxes, Heidelberg has taken up a leading position in a market that is enjoying rapid growth.
  • Demand for our products is booming, and we\'ve significantly exceeded our sales targets for financial year 2020/21.
  • Customers appreciate the high quality, reliability, and robustness of Heidelberg wallboxes, and also their simple and versatile operation.

DGAP-News: Heidelberger Druckmaschinen AG: New perspectives for the Print Media Academy in Heidelberg

Retrieved on: 
Tuesday, February 2, 2021

Heidelberger Druckmaschinen AG (Heidelberg) continues to systematically implement its strategic agenda: As part of the planned site and structural optimization measures, the company is selling the Print Media Academy (PMA) in Heidelberg to a Luxembourg-based investment company.

Key Points: 
  • Heidelberger Druckmaschinen AG (Heidelberg) continues to systematically implement its strategic agenda: As part of the planned site and structural optimization measures, the company is selling the Print Media Academy (PMA) in Heidelberg to a Luxembourg-based investment company.
  • The sale paves the way for a new, forward-looking use of the building at a central location in the city.
  • With this in mind, Heidelberg had already moved the few employees still working at PMA to Wiesloch/Walldorf in 2020.
  • Heidelberg IR now on Twitter:
    Link to the IR Twitter channel: https://twitter.com/Heidelberg_IR
    On Twitter under the name: @Heidelberg_IR

DGAP-News: Heidelberger Druckmaschinen AG: Heidelberg aims to strengthen its competitive position in the growth market of China - production joint venture agreed with Masterwork

Retrieved on: 
Wednesday, December 2, 2020

Heidelberger Druckmaschinen AG (Heidelberg) aims to further strengthen its leading competitive position in the growth market of China and has therefore set up a production joint venture with its long-standing partner and strategic anchor shareholder Masterwork Group Co., Ltd. (Masterwork).

Key Points: 
  • Heidelberger Druckmaschinen AG (Heidelberg) aims to further strengthen its leading competitive position in the growth market of China and has therefore set up a production joint venture with its long-standing partner and strategic anchor shareholder Masterwork Group Co., Ltd. (Masterwork).
  • "The manufacturing joint venture with Masterwork is a further milestone in the successful cooperation between the two companies and opens up additional opportunities for Heidelberg in China," said Rainer Hundsdrfer, CEO of Heidelberg.
  • We have increasingly strengthened our leading market position by expanding our range of products at our production site near Shanghai.
  • Under the terms of the cooperation agreement, the joint venture will take over some of the machine parts previously manufactured by Heidelberg.

DGAP-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020

Retrieved on: 
Thursday, October 8, 2020

Ladenburg, Germany, 8 October 2020 - Heidelberg Pharma AG (FSE: HPHA) today reported on the first nine months of fiscal year 2020 (1 December 2019 - 31 August 2020) and the Group's financial figures.

Key Points: 
  • Ladenburg, Germany, 8 October 2020 - Heidelberg Pharma AG (FSE: HPHA) today reported on the first nine months of fiscal year 2020 (1 December 2019 - 31 August 2020) and the Group's financial figures.
  • The Heidelberg Pharma Group - as of the reporting date comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH - reports consolidated figures.
  • For 2020, Heidelberg Pharma anticipates cash requirements of EUR 18.0 million to EUR 20.0 million (previously: EUR 11.0 million to EUR 15.0 million).
  • The complete figures for the interim financial statements can be downloaded from http://www.heidelberg-pharma.com / "Press & Investors > Financial Reports > Interim Management Statement of 8 October 2020".

DGAP-News: Heidelberg Pharma AG: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions

Retrieved on: 
Wednesday, July 22, 2020

Ladenburg, Germany, 22 July 2020 - Heidelberg Pharma AG (FSE: HPHA) today announced that the shareholders of the Company approved the resolutions of the administration with large majorities (ranged from 98.65% to 99.99%) during the virtual Annual General Meeting today.

Key Points: 
  • Ladenburg, Germany, 22 July 2020 - Heidelberg Pharma AG (FSE: HPHA) today announced that the shareholders of the Company approved the resolutions of the administration with large majorities (ranged from 98.65% to 99.99%) during the virtual Annual General Meeting today.
  • At the Annual General Meeting 2020, 81.48% of the current share capital were represented.
  • Please find more information about the Annual General Meeting including the voting results here: http://heidelberg-pharma.com/en/press-and-investors/annual-general-meeting .
  • Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies.

DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma reports on first half-year 2020

Retrieved on: 
Thursday, July 9, 2020

The Heidelberg Pharma Group (Heidelberg Pharma) - comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH - reports consolidated figures.

Key Points: 
  • The Heidelberg Pharma Group (Heidelberg Pharma) - comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH - reports consolidated figures.
  • The Heidelberg Pharma Group expanded its net loss for the first six months of 2020 from EUR 4.3 million in the previous year to EUR 9.4 million.
  • Heidelberg Pharma had cash and cash equivalents of EUR 15.1 million on 31 May 2020 (30 November 2019: EUR 9.9 million).
  • Heidelberg Pharma confirms its guidance for the current fiscal year provided on 19 March 2020.

DGAP-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020

Retrieved on: 
Thursday, April 23, 2020

The Heidelberg Pharma Group - as of the reporting date comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH - reports consolidated figures.

Key Points: 
  • The Heidelberg Pharma Group - as of the reporting date comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH - reports consolidated figures.
  • Heidelberg Pharma expects to require funds of EUR 11.0 million to EUR 15.0 million in 2020.
  • Heidelberg Pharma will not host a conference call on this interim management statement.
  • The complete figures for the interim financial statements can be downloaded from http://www.heidelberg-pharma.com/ "Press & Investors > Financial Reports > Interim management statement on the first three months of 2020".